期刊
CANCER CYTOPATHOLOGY
卷 124, 期 6, 页码 406-414出版社
WILEY
DOI: 10.1002/cncy.21699
关键词
epidermal growth factor receptor (EGFR); fine-needle aspiration; KRAS; lung carcinoma; massive parallel sequencing
资金
- Department of Pathology and Laboratory Medicine of the University of North Carolina
- University Cancer Research Fund
- University of North Carolina Clinical Translational Science Award (National Institutes of Health) [UL1TR001111]
- UNC Health Care
- National Institutes of Health [UL1TR001111, U01HG006487, 1U19HD077632-01]
BACKGROUND: Diff-Quik-stained fine-needle aspiration (FNA) smears and touch preparations from biopsies represent alternative specimens for molecular testing when cell block or biopsy material is insufficient. This study describes the use of these samples for targeted next-generation sequencing (NGS) of primary and metastatic lung adenocarcinoma and reports the DNA quality and success rates of FNA smears versus other specimens from 1 year of clinical use. METHODS: A validation set of 10 slides from 9 patients with prior clinical epidermal growth factor receptor (EGFR) Sanger sequencing and KRAS pyrosequencing (5 KRAS-positive/EGFR-negative and 4 KRAS-negative/EGFR-negative) underwent DNA extraction, quality assessment, and targeted NGS. Subsequently, lung adenocarcinoma specimens submitted for NGS solid tumor mutation panel testing in 1 calendar year (60 biopsies, 57 resections, 33 FNA cell blocks, 12 FNA smears, and 10 body fluid cell blocks) were reviewed for specimen adequacy, sequencing success, and DNA quality. RESULTS: All 10 validation samples met the DNA quality threshold (delta C-t threshold < 8; range, -2.2 to 4.9) and yielded 0.5 to 22 mu g of DNA. The KRAS and EGFR mutation status from FNA smears according to NGS was concordant with previous clinical testing for all 10 samples. In the 1-year review, FNA smears were 100% successful, and this suggested a performance equivalent to or better than the performance of established specimen types, including FNA cell blocks. DNA quality according to Delta C-t was significantly better with FNA smears versus biopsies, resections, and FNA cell blocks. CONCLUSIONS: FNA smears of lung adenocarcinomas are high-quality alternative specimens for a targeted NGS panel with a high success rate in clinical practice. (C) 2016 American Cancer Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据